REDDY-BOSUTINIB DIN 02560038
Status: Marketed
Holder: DR REDDY'S LABORATORIES LTD
Health Canada record
| Active ingredient(s) | BOSUTINIB (BOSUTINIB DIHYDRATE) 100 MG |
|---|
| Dosage form | Tablet |
|---|
| Route | Oral |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Human |
|---|
| ATC | L01EA04 BOSUTINIB |
|---|
| Original market date | 08-Sep-2025 |
|---|
| Current status date | 08-Sep-2025 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Dr Reddy's Laboratories (UK) Limited — licence , not currently licensed, last inspection rating C (2019-02-12).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing BOSUTINIB (BOSUTINIB DIHYDRATE)
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02560011 | REDDY-BOSUTINIB | DR REDDY'S LABORATORIES LTD | Tablet | BOSUTINIB (BOSUTINIB DIHYDRATE) 400 MG | Approved |
| 02560046 | REDDY-BOSUTINIB | DR REDDY'S LABORATORIES LTD | Tablet | BOSUTINIB (BOSUTINIB DIHYDRATE) 500 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 35817 | 2025-08-11 | Abbreviated New Drug Submission (ANDS) | |
Request a quote for REDDY-BOSUTINIB
How to read a Canadian DIN record